Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

NCT04947826 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma With Major Portal Vein Thrombosis

Interventions

PROCEDURE: HAIC (Hepatic arterial infusion chemotherapy)
DRUG: HLX10 (PD-1 antibody)
DRUG: HLX04 (VEGF antibody)
DRUG: Placebo

Sponsor

Shanghai Zhongshan Hospital

Collaborators

[object Object]